Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia
暂无分享,去创建一个
H. Whittle | U. d’Alessandro | R. Goldin | C. Bottomley | S. Moore | M. Thursz | I. Baldeh | M. Lemoine | R. Njie | R. Wegmuller | M. Taal | Y. Shimakawa | H. Njai | M. Mendy | G. Ndow | Abdoulie Jatta | A. Jeng-Barry | Rita Wegmuller
[1] A. Hall,et al. Birth order and risk of hepatocellular carcinoma in chronic carriers of hepatitis B virus: a case–control study in The Gambia , 2015, Liver international : official journal of the International Association for the Study of the Liver.
[2] Maimuna Mendy,et al. Validation of Rapid Point-of-Care (POC) Tests for Detection of Hepatitis B Surface Antigen in Field and Laboratory Settings in the Gambia, Western Africa , 2015, Journal of Clinical Microbiology.
[3] S. Sodha,et al. Global Routine Vaccination Coverage, 2013 , 2014, MMWR. Morbidity and mortality weekly report.
[4] E. Gane,et al. Serological and clinical outcomes of horizontally transmitted chronic hepatitis B infection in New Zealand Māori: results from a 28-year follow-up study , 2014, Gut.
[5] M. Thursz,et al. Prevention of materno‐foetal transmission of hepatitis B in sub‐Saharan Africa: the evidence, current practice and future challenges , 2014, Journal of viral hepatitis.
[6] C. Bottomley,et al. The association between maternal hepatitis B e antigen status, as a proxy for perinatal transmission, and the risk of hepatitis B e antigenaemia in Gambian children , 2014, BMC Public Health.
[7] A. Hall,et al. Population-Based Interventions to Reduce the Public Health Burden Related with Hepatitis B Virus Infection in The Gambia, West Africa , 2014, Tropical medicine and health.
[8] H. Whittle,et al. Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986–90) and in the nationwide immunisation program , 2014, BMC Infectious Diseases.
[9] P. Hainaut,et al. 20-Years of Population-Based Cancer Registration in Hepatitis B and Liver Cancer Prevention in The Gambia, West Africa , 2013, PloS one.
[10] A. Hall,et al. Association of Early Age at Establishment of Chronic Hepatitis B Infection with Persistent Viral Replication, Liver Cirrhosis and Hepatocellular Carcinoma: A Systematic Review , 2013, PloS one.
[11] H. Whittle,et al. Observational Study of Vaccine Efficacy 24 Years after the Start of Hepatitis B Vaccination in Two Gambian Villages: No Need for a Booster Dose , 2013, PloS one.
[12] A. Hall,et al. Evaluation of data quality at the Gambia national cancer registry , 2013, International journal of cancer.
[13] B. Cowie,et al. The global burden of liver disease attributable to hepatitis B, hepatitis C, and alcohol: increasing mortality, differing causes , 2013 .
[14] Chien-Jen Chen,et al. Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma. , 2011, Gastroenterology.
[15] H. Whittle,et al. Seasonal Variation in TP53 R249S-Mutated Serum DNA with Aflatoxin Exposure and Hepatitis B Virus Infection , 2011, Environmental health perspectives.
[16] S. Hadziyannis. Natural history of chronic hepatitis B in Euro-Mediterranean and African countries. , 2011, Journal of hepatology.
[17] Penelope Vounatsou,et al. Geostatistical Model-Based Estimates of Schistosomiasis Prevalence among Individuals Aged ≤20 Years in West Africa , 2011, PLoS neglected tropical diseases.
[18] C. Chu,et al. Age‐specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B , 2010, Hepatology.
[19] Norman Gitlin,et al. Chronic hepatitis B : an update , 2010 .
[20] B. McMahon,et al. Chronic hepatitis B: Update 2009 , 2009, Hepatology.
[21] Mei‐Hwei Chang. Natural history and clinical management of chronic hepatitis B virus infection in children , 2008, Hepatology international.
[22] H. Whittle,et al. Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia , 2008, Virology Journal.
[23] B. McMahon,et al. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. , 2007, Gastroenterology.
[24] M. Kew,et al. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.
[25] C. Chu,et al. Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion , 2007, Journal of viral hepatitis.
[26] P. Loehrer,et al. Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level , 2007 .
[27] H. Whittle,et al. Long-term protection against carriage of hepatitis B virus after infant vaccination. , 2006, The Journal of infectious diseases.
[28] A. Gatta,et al. Chronic hepatitis B in children after e antigen seroclearance: Final report of a 29‐year longitudinal study , 2006, Hepatology.
[29] Guan-Tarn Huang,et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. , 2006, JAMA.
[30] H. Whittle,et al. Application of real-time PCR to quantify hepatitis B virus DNA in chronic carriers in The Gambia , 2006, Virology Journal.
[31] A. Hall,et al. Chronic hepatitis B virus infection in the Asia–Pacific region and Africa: Review of disease progression , 2005, Journal of gastroenterology and hepatology.
[32] S. Akçalı,et al. Serum hepatitis B DNA: stability in relation to multiple freeze-thaw procedures. , 2005, Journal of virological methods.
[33] A. Hall,et al. Mortality of hepatitis B surface antigen-positive blood donors in England and Wales. , 2003, International journal of epidemiology.
[34] D. Shouval. Hepatitis B vaccines. , 2003, Journal of hepatology.
[35] H. Whittle,et al. Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children , 2002, BMJ : British Medical Journal.
[36] B. McMahon,et al. Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus , 2001, Annals of Internal Medicine.
[37] W. Mason,et al. Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[38] W. Edmunds,et al. Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areasr , 1996, Epidemiology and Infection.
[39] P. Bedossa,et al. An algorithm for the grading of activity in chronic hepatitis C , 1996, Hepatology.
[40] C. Kiire. The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa. , 1996, Gut.
[41] H. Whittle,et al. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages , 1995, The Lancet.
[42] K. Hyams. Risks of chronicity following acute hepatitis B virus infection: a review. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[43] H. Inskip,et al. Vaccination aginst chronic viral carriage in The Gambia , 1991, The Lancet.
[44] H. Inskip,et al. Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia. , 1991, Lancet.
[45] H. Inskip,et al. The pattern of childhood hepatitis B infection in two Gambian villages. , 1990, The Journal of infectious diseases.
[46] H. Whittle,et al. HEPATITIS B VIRUS INFECTION IN TWO GAMBIAN VILLAGES , 1983, The Lancet.
[47] M. Kew,et al. Hepatocellular Carcinoma in Rural Southern African Blacks , 1982, Medicine.
[48] I. McGregor. Health and communicable disease in a rural African environment , 1976 .
[49] M. Dumont,et al. European Association for the Study of the Liver , 1971 .
[50] M. Graffar. [Modern epidemiology]. , 1971, Bruxelles medical.
[51] Hepatitis A vaccines WHO position paper , 2022 .